NCT00135733View on ClinicalTrials.gov

A Safety and Efficacy Study of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus

PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Lichen Planus
Interventions
DRUG

Amevive (Alefacept)

DRUG

Placebo

Trial Locations (1)

02115

Clinical Unit for Research Trials in Skin, Boston

Sponsors

Collaborators (1)

Biogen
All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Stanford University

OTHER

collaborator

Biogen

INDUSTRY

lead

Massachusetts General Hospital

OTHER